GlassScriptPhysician profile
Christopher K Craig
NPI 1427214014
$8,786.24
in general payments reported to CMS, 2019-2025
13 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,897 · 2022: $2,326 · 2023: $1,659 · 2024: $619 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $970 · Honoraria: $900 · Travel and Lodging: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $969.51 |
| Honoraria | $900.00 |
| Travel and Lodging | $694.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $4,327.15 | 2021-2022 | |
| Avita Medical Americas, LLC | $3,051.82 | 2021-2023 | Recell |
| Integra Lifesciences Corporation | $336.62 | 2021-2022 | |
| Smith+Nephew, INC. | $163.11 | 2023-2024 | Renasys Touch, Pico |
| Medtronic, INC. | $148.44 | 2024 | Kyphon Express II Kyphopak Tray |
| Astrazeneca Pharmaceuticals LP | $124.46 | 2025 | Tezspire |
| Aroa Biosurgery Incorporated | $120.53 | 2025 | |
| Novo Nordisk INC | $114.30 | 2024 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $111.26 | 2024 | |
| Merck Sharp & Dohme LLC | $102.88 | 2024 | Capvaxive |
| Amgen INC. | $101.14 | 2021 | |
| Boston Scientific Corporation | $44.20 | 2024 | |
| Globus Medical, INC. | $40.33 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Craig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.